Table 1 Baseline characteristics of the 117 patients with acute myeloid leukaemia
Characteristics | Total(N = 117) | ||
|---|---|---|---|
N | Median(range) | % | |
Age | 67(60–87) | ||
Sex | |||
Male | 64 | 54.7 | |
Female | 53 | 45.3 | |
ECOG | |||
0–2 | 96 | 82.1 | |
≥ 3 | 21 | 17.9 | |
Diagnosis | |||
M0 | 3 | 2.6 | |
M1 | 19 | 16.2 | |
M2 | 57 | 48.7 | |
M4 | 8 | 6.8 | |
M5 | 18 | 15.4 | |
M6 | 10 | 8.6 | |
Unknown | 2 | 1.7 | |
Primary karyotype | |||
Good | 1 | 0.8 | |
Intermediate | 89 | 76.1 | |
Poor | 18 | 15.4 | |
Unavailable | 9 | 7.7 | |
FLT3-ITD mutation | |||
Positive | 13 | 11.1 | |
Negative | 88 | 75.2 | |
Missing | 16 | 13.7 | |
NPM1 mutation | |||
Positive | 24 | 20.5 | |
Negative | 78 | 66.7 | |
Missing | 15 | 12.8 | |
CEBPα mutation | |||
Positive | 16 | 13.7 | |
Negative | 81 | 69.2 | |
Missing | 20 | 17.1 | |
C-Kit mutation | |||
Positive | 4 | 3.5 | |
Negative | 94 | 80.3 | |
Missing | 19 | 16.2 | |
Initial CBC | |||
WBC(×109/L) | 6.92(0.3–310.3) | ||
Hb(×g/L) | 84(47–139) | ||
PLT(×109/L) | 49(8–804) | ||